SGEN Stock Jumps 16% in Pre-Market as Merck Set to Purchase $1B Stake in Seattle Genetics

Coinspeaker SGEN Stock Jumps 16% in Pre-Market as Merck Set to Purchase $1B Stake in Seattle GeneticsIt is a strategic partnership that will see both Merck and Seattle Genetics venture new market opportunities as the market demand for specialized and less harmful drugs sharply increases amid the crisis. дальше »

231 +